The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
High prevalence of dysfibrinogenemia among patients with chronic thromboembolic pulmonary hypertension
Open accessAbstract
The mechanism by which chronic thromboembolic pulmonary hypertension (CTEPH) develops after acute pulmonary thromboembolism is unknown. We previously reported that fibrin from CTEPH patients is relatively resistant to fibrinolysis in vitro. In the present study, we performed proteomic, genomic, and functional studies on fibrin(ogen) to investigate whether abnormal fibrin(ogen) might contribute to the pathogenesis of CTEPH. Reduced and denatured fibrinogen from 33 CTEPH patients was subjected to liquid chromatography–mass spectrometry analysis. Fibrinogen from 21 healthy controls was used to distinguish atypical from commonly occurring mass peaks. Atypical peaks were further investigated by targeted genomic DNA sequencing. Five fibrinogen variants with corresponding heterozygous gene mutations (dysfibrinogenemias) were observed in 5 of 33 CTEPH patients: Bβ P235L/γ R375W, Bβ P235L/γ Y114H, Bβ P235L, Aα L69H, and Aα R554H (fibrinogensSan Diego I-V). Bβ P235L was found in 3 unrelated CTEPH patients. Functional analysis disclosed abnormalities in fibrin polymer structure and/or lysis with all CTEPH-associated mutations. These results suggest that, in some patients, differences in the molecular structure of fibrin may be implicated in the development of CTEPH after acute thromboembolism.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Moreno, V., Martin, M. L., Bosch, F. X., de Sanjose, S., Torres, F., & Munoz, N. (1996) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a008741 · Cited by 20
Cited by
2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism
Authors/Task Force Members, Konstantinides, S. V., Torbicki, A., Agnelli, G., Danchin, N., Fitzmaurice, D., Galiè, N., Gibbs, J. S. R., Huisman, M. V., Humbert, M., et al. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu283 · Cited by 3,128
The pathophysiology of chronic thromboembolic pulmonary hypertension
Simonneau, G., Torbicki, A., Dorfmüller, P., & Kim, N. (2017) · European Respiratory Review · doi:10.1183/16000617.0112-2016 · Cited by 461
Lang, I. M., Pesavento, R., Bonderman, D., & Yuan, J. X.-J. (2013) · European Respiratory Journal · doi:10.1183/09031936.00049312 · Cited by 456
The post-PE syndrome: a new concept for chronic complications of pulmonary embolism
Klok, F. A., van der Hulle, T., den Exter, P. L., Lankeit, M., Huisman, M. V., & Konstantinides, S. (2014) · Blood Reviews · doi:10.1016/j.blre.2014.07.003 · Cited by 441
Risk factors for chronic thromboembolic pulmonary hypertension
Bonderman, D., Wilkens, H., Wakounig, S., Schäfers, H.-J., Jansa, P., Lindner, J., Simkova, I., Martischnig, A. M., Dudczak, J., Sadushi, R., et al. (2009) · European Respiratory Journal · doi:10.1183/09031936.00087608 · Cited by 441
Metadata
- Authors
- Morris, T. A., Marsh, J. J., Chiles, P. G., Magaña, M. M., Liang, N.-C., Soler, X., DeSantis, D. J., Ngo, D., & Woods, V. L.
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 2009-08-27
- Volume
- 114
- Issue
- 9
- Pages
- 1929-1936
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- OpenAlex
- W2053546643
- Cited by
- 163
- References
- 1
- FWCI
- 6.86
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: High prevalence of dysfibrinogenemia among patients with chronic thromboembolic pulmonary hypertension. https://app.cochat.ai/papers/10.1182/blood-2009-03-208264
- The paper
- Morris, T. A., Marsh, J. J., Chiles, P. G., Magaña, M. M., Liang, N.-C., Soler, X., DeSantis, D. J., Ngo, D., & Woods, V. L. (2009). High prevalence of dysfibrinogenemia among patients with chronic thromboembolic pulmonary hypertension. Blood. https://doi.org/10.1182/blood-2009-03-208264
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.